Petri People

What better way to study a disease than by looking at cells from a patient? Researchers are using induced pluripotent stem cell technology to generate cells from patients with Parkinson's disease, diabetes, and Down syndrome, among others, Technology Review's Emily Singer reports. "By differentiating these cells into the cell type affected in the disease, scientists can search for molecular missteps unique to these cells," Singer says.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.